期刊文献+

人乳头瘤病毒感染与原发性肺癌相关性研究 被引量:3

Association between human papillomavirus infection and lung cancer
原文传递
导出
摘要 目的 探索HPV感染与原发性肺癌的关联。方法 检测83对匹配的肺癌和癌旁正常组织中HPV感染情况。采用HPV高保守L1区PCR扩增和特异探针反向杂交相结合的方法,检测21种临床相关的HPV型别。应用配对 χ2检验分析肺癌与癌旁正常组织HPV检出率差异。应用 χ2检验及确切概率法分析不同性别、年龄、组织学类型、临床分期、吸烟和饮酒情况下肺癌组织HPV检出率差异。结果 7份肺癌组织和6份癌旁正常组织检出HPV,HPV阳性率在肺癌与癌旁正常组织间差异无统计学意义(P〉0.999)。在不同性别、年龄、吸烟、饮酒,不同病理类型、临床分期和淋巴结转移情况下,肺癌组织HPV检出率差异无统计学意义(P〉0.05)。结论 在福建人群中未发现HPV感染与原发性肺癌发生风险有明显关联。 Objective To investigate the association between human papillomavirus (HPV) and lung cancer. Methods We examined a series of 83 lung cancer patients with HPV DNA in both lung tumor specimens and adjacent normal specimens from Fujian province. Twenty-one of the most clinically relevant HPV types from the highly conserved L1 region of the viral genome were analyzed, using the PCR amplification and were followed by reverse hybridization with specific probes. Chi-square test of paired design was used to test the difference of HPV positive rates between lung cancer specimens and adjacent normal specimens. Chi-square test and Fisher's exact test were used to analyze the differences of HPV positive rate of tumor specimens on factors as gender, age, histological subtype, clinical stage, smoking status and alcohol consumption. Results HPV was detected in 7 of the 83 tumor specimens and in 6 of the paired normal lung tissues. There was no significant correlation between HPV and lung cancer (P〉0.999). Neither demographic characteristics nor clinical features were found with significant differences on HPV in lung cancer tissues (P〉0.05). Conclusion Our data showed that HPV was not significantly associated with the risk of lung cancer in Fujian province.
作者 熊为旻 何斐 肖仁栋 俞婷婷 张鑫 刘志强 徐秋萍 蔡琳 Xiong Weimin He Fei Xiao Rendong Yu Tingting Zhang Xin Liu Zhiqiang Xu Qiuping Cai Lin(Department of Epidemiology and Health Statistics, School of Public Health, Fujian Medical University, Fuzhou 350108, China Department of Chest Surgery, The First Altliated Hospital of Fujian Medical University, Fuzhou 350001, China)
出处 《中华流行病学杂志》 CAS CSCD 北大核心 2016年第12期1658-1661,共4页 Chinese Journal of Epidemiology
基金 国家自然科学基金(81172766,81402738) 福建省卫生计生委青年科研项目(2014-1-37) 福建省卫生教育联合攻关项目(WKJ-FJ-18) 福建医科大学博士启动基金项目(2014MP006)
关键词 人类乳头瘤病毒 肿瘤 生物标志 Human papillomavirus Lung neoplasms Biomarker
  • 相关文献

参考文献1

二级参考文献12

  • 1Syrjanen KJ. Bronchial squamous cell carcinomas associated with epithelial changes identical to condylomatous lesions of the uterine cervix[J]. Lung, 1980, 158 (3): 131-142.
  • 2Wang Y, Wang A, Jiang R, et al. Human papillomavirus type 16 and 18 infection is associated with lung cancer patients from the central part of China[J]. Oncol Rep, 2008, 20 (2): 333- 339.
  • 3Zhang EY, Tang XD. Human papillomavirus type 16/18 oncoproteins: potential therapeutic targets in non-smoking associated lung cancer[J]. Asian Pae J Cancer Prey, 2012, 13 (11): 5363-5369.
  • 4Syrj/inen KJ. Epithelial lesions suggestive of a condylomatousorigin found closely associated with invasive bronchial squamous cell carcinomas[J]. Respiration, 1980, 40 (3): 150-160.
  • 5Bosch FX, de Sanjose S, Castellsague X. The prospects of HPV vaccination in cervical cancer prevention: results of a new independent trial[J]. Cancer Discov, 2011, 1 (5): 377-380.
  • 6Zur HH. Papillomaviruses and cancer: from basic study to clinical application [J]. Nat Rev Cancer, 2002, 2 (5) : 342-350.
  • 7Shiboski CH, Schmidt BL, Jordan RC. Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20-44 years[J]. Cancer, 2005, 103 (9): 1843-1849.
  • 8Dayyani F, Etzel C J, Liu M, et al. Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC)[J]. Head Neck Oncol, 2010, 2: 15.doi: 10.1186/ 1758-3284-2-15.
  • 9Saslow D, Castle PE, Cox JT, et al. American cancer society guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors[J]. CA Cancer J Clin, 2007, 57 (1): 7-28.
  • 10Joura EA, Leodolter S, Hernandez-Avila M, et al. Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high- grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials[J]. Lancet, 2007, 369 (9574): 1693-1702.

共引文献2

同被引文献13

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部